DR

Denny S. Roja

Executive Vice President - Legal And Corporate Development; Vice Chair Of Board Of Directors at GeneHarmonics Inc.

Denny S. Roja is a seasoned executive and legal professional with extensive experience in corporate law, venture advisory, and management. Currently serving as Chairman & CEO of GeneHarmonics Inc. and Harmonix HR, Denny also holds the position of Attorney at Law and Managing Partner at Venture Law Partners P.C., specializing in General Counsel services for startups. As Managing Director at VentureQuest, LLC, and Co-founder, CFO, and Legal Counsel at iSenseCloud, Denny demonstrates a strong capability in corporate development and legal strategy. Denny has co-founded LiVeritas Biosciences and provided legal counsel to multiple startups, including Daxa, Inc., while advising the Science & Technology Advisory Council in Silicon Valley. Denny’s educational credentials include multiple advanced degrees in business and law from prestigious institutions such as Stanford University and Fordham University, complemented by a strong foundation in chemical engineering from the University of Washington and the University of Santo Tomas.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


GeneHarmonics Inc.

Core Beliefs: • Creating innovative enterprise solutions with social relevance. • Anchoring our initiatives to existing global and/or regional infrastructures for accelerated growth. • The principle that success should be measured using both financial and social impact metrics. GeneHarmonics Inc., is a next generation medical technology company in 2021. GeneHarmonics leverages converging technologies to enhance medical diagnostics. GeneHarmonics’ foundational technology has the capability to test various biomarker classifications inclusive of, but not limited to, infectious diseases, direct to consumer tests, and population studies, etc. The Harmonics Group of Companies formally started 2.5 years ago and has grown revenue to 8-figures in a short span of time. Exposed to the interplay between technology companies and the capital market in Silicon Valley, GeneHarmonics created and implemented a non-traditional plan to create a funding engine for the diagnostics platform. This strategy is inclusive of consolidating end-to-end self-sustaining verticals globally to help address societal needs. The Harmonics Group is composed of companies structured around the principles of social entrepreneurship. The Harmonics Group adheres to the strict strategic planning principles, consolidation, and the accelerated implementation of out-of-the box solutions to address several critical issues inclusive of, but not limited to: data-enabled portable devices to be used as research tools for the management of infectious diseases; the human resources crisis in major economies; creating better healthcare solutions for applicable US workforce.


Employees

1-10

Links